068330 — Ilshinbiobase Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapContrarian

Annual balance sheet for Ilshinbiobase Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS/A	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	17,560	20,152	25,577	27,712	33,493
Net Total Accounts Receivable
Net Total Receivables	4,017	4,633	4,251	4,322	2,714
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	28,985	32,018	38,171	41,175	46,528
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10,866	11,218	10,842	10,698	10,433
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	45,626	49,548	56,439	58,451	60,618
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5,250	4,758	5,950	4,425	3,445
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	5,466	5,169	6,359	4,632	3,554
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	40,160	44,379	50,080	53,819	57,064
Total Liabilities & Shareholders' Equity	45,626	49,548	56,439	58,451	60,618
Total Common Shares Outstanding